Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 5
1967 6
1968 6
1969 7
1970 6
1971 5
1972 3
1973 3
1974 3
1975 4
1976 2
1977 1
1978 1
1980 2
1981 1
1983 1
1989 1
1991 1
1994 1
1995 1
2006 1
2011 1
2015 1
2016 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Parsell D, Shao J, Guttendorf R, Mathur V, Li E, Wu YS, Tsao L, Tabakman S, Stasiv Y, Lee A, Biyani K, Klaerner G. Parsell D, et al. Drug Metab Dispos. 2021 Jul;49(7):490-500. doi: 10.1124/dmd.121.000366. Epub 2021 May 24. Drug Metab Dispos. 2021. PMID: 34031138 Clinical Trial.
Veverimer is a polymer being developed as a potential treatment of metabolic acidosis in patients with chronic kidney disease. Veverimer selectively binds and removes hydrochloric acid from the gastrointestinal tract, resulting in an increase in serum bicarbonate. ...Three …
Veverimer is a polymer being developed as a potential treatment of metabolic acidosis in patients with chronic kidney disease. Veverimer sel …
Furosemide versus ethacrynic acid in pediatric patients undergoing cardiac surgery: a randomized controlled trial.
Ricci Z, Haiberger R, Pezzella C, Garisto C, Favia I, Cogo P. Ricci Z, et al. Crit Care. 2015 Jan 7;19(1):2. doi: 10.1186/s13054-014-0724-5. Crit Care. 2015. PMID: 25563826 Free PMC article. Clinical Trial.
INTRODUCTION: Clinical effects of furosemide (F) and ethacrynic acid (EA) continuous infusion on urine output (UO), fluid balance, and renal, cardiac, respiratory, and metabolic function were compared in infants undergoing surgery for congenital heart diseases. ...
INTRODUCTION: Clinical effects of furosemide (F) and ethacrynic acid (EA) continuous infusion on urine output (UO), fluid bala …
Clinical Factors Associated with Dose of Loop Diuretics After Pediatric Cardiac Surgery: Post Hoc Analysis.
Haiberger R, Favia I, Romagnoli S, Cogo P, Ricci Z. Haiberger R, et al. Pediatr Cardiol. 2016 Jun;37(5):913-8. doi: 10.1007/s00246-016-1367-x. Epub 2016 Mar 9. Pediatr Cardiol. 2016. PMID: 26961571 Clinical Trial.
At multivariable logistic regression cross-clamp time (OR 1.007, p = 0.04), use of ethacrynic acid (OR 0.2, p = 0.01) and blood pH at the end of POD0 (OR 0.0001, p = 0.03) was independently associated with diuretic dose. ...Independently associated variables with di …
At multivariable logistic regression cross-clamp time (OR 1.007, p = 0.04), use of ethacrynic acid (OR 0.2, p = 0.01) and bloo …
Alternating sequential dosing with furosemide and ethacrynic acid in drug tolerance in the newborn.
Chemtob S, Doray JL, Laudignon N, Papageorgiou A, Varma DR, Aranda JV. Chemtob S, et al. Am J Dis Child. 1989 Jul;143(7):850-4. doi: 10.1001/archpedi.1989.02150190100032. Am J Dis Child. 1989. PMID: 2741861 Clinical Trial.
In a randomized double crossover study, we examined the diuretic and saliuretic effects of alternating doses of furosemide and ethacrynic acid (1 mg/kg administered intravenously every 24 hours) in 10 newborns, who received the drugs in the following sequential orde …
In a randomized double crossover study, we examined the diuretic and saliuretic effects of alternating doses of furosemide and ethacrynic
A comparison of the effects of inhaled furosemide and ethacrynic acid on sodium-metabisulfite-induced bronchoconstriction in subjects with asthma.
Pye S, Pavord I, Wilding P, Bennett J, Knox A, Tattersfield A. Pye S, et al. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):337-9. doi: 10.1164/ajrccm.151.2.7842188. Am J Respir Crit Care Med. 1995. PMID: 7842188 Clinical Trial.
Eight subjects with mild asthma were studied on five occasions, receiving nebulized furosemide (20 and 40 mg), ethacrynic acid (25 and 50 mg), or placebo (normal saline) in random order and double-blind 10 min before a cumulative dose challenge with inhaled sodium m …
Eight subjects with mild asthma were studied on five occasions, receiving nebulized furosemide (20 and 40 mg), ethacrynic acid
Potassium-sparing effect of amiloride in a diuretic factorial study in man.
Schapel GJ, Edwards DG, Robinson J. Schapel GJ, et al. Clin Exp Pharmacol Physiol. 1975 Jul-Aug;2(4):277-87. doi: 10.1111/j.1440-1681.1975.tb01834.x. Clin Exp Pharmacol Physiol. 1975. PMID: 1097143 Clinical Trial.
The effects of amiloride (M, 20 mg/day), chlorothiazide (C, 1000 mg/day), ethacrynic acid (E, 100 MG/day) and frusemide (F, furosemide 80 mg/day, given alone and in combination, were investigated in eight patients in a 2(4) factorial study. ...All patients exhibited …
The effects of amiloride (M, 20 mg/day), chlorothiazide (C, 1000 mg/day), ethacrynic acid (E, 100 MG/day) and frusemide (F, fu …
69 results